Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (ANIK) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
anik · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $14.60
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.44 | ↓ 1.07% |
1-day model range: $14.3–$14.58. Peak: $14.58 (-1.07%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $15 | +3.2% |
| 2028 | $15 | +4.9% |
| 2029 | $15 | +5.7% |
| 2030 | $16 | +6.2% |
| 2031 | — | +6.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ANIK · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-27 | Barrington Research | Maintains | Outperform→Outperform |
| 2026-01-09 | Barrington Research | Maintains | Outperform→Outperform |
| 2025-11-06 | Barrington Research | Maintains | Outperform→Outperform |
| 2025-09-23 | Barrington Research | Maintains | Outperform→Outperform |
| 2025-07-31 | Barrington Research | Maintains | Outperform→Outperform |
| 2025-05-12 | Barrington Research | Maintains | Outperform→Outperform |
| 2025-03-13 | Barrington Research | Maintains | Outperform→Outperform |
| 2024-11-01 | Barrington Research | Maintains | Outperform→Outperform |
| 2024-10-22 | Barrington Research | Maintains | Outperform→Outperform |
| 2024-08-09 | Barrington Research | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Anika Therapeutics, Inc. (ANIK) stock. Of the recent 35 rating actions, 7 were upgrades and 8 were downgrades. 6 analysts currently cover ANIK.
Analyst Recommendation Trends
ANIK analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$150M
↑ 26.6% YoY
Revenue Next Year
$111M
↓ 26.1% YoY
EPS This Year
$0.10
EPS Next Year
$-0.61
↓ 715.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ANIK EPS of $0.10 for the current fiscal year, based on estimates from 1 analysts. The ANIK revenue forecast is $150M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ANIK stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ANIK price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The ANIK short-term stock prediction for tomorrow is $14.44 (-1.07%). The ANIK stock price prediction for 2027 estimates an average of $15. The ANIK stock prediction for 2030 projects a range of $14–$17.
Anika Therapeutics, Inc. trades on NASDAQ under the ticker ANIK. The ANIK stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
ANIK forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month ANIK price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $14.60.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.